newsfilter
← Latest News
Business Wire·

Athersys Reschedules Third Quarter Conference Call to November 15

Athersys, Inc. (NASDAQ:ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today that it intends to file its quarterly report on Form 10-Q for the